An Open-Label Phase 2 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Patients With Treatment-Resistant, Metastatic Pancreatic or Colorectal Adenocarcinoma
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2019
Price : $35 *
At a glance
- Drugs Encapsulated cell therapy (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms Macrobead
- 04 Jun 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Oct 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
- 09 Oct 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.